HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO.TO) was honoured for product innovation with two prestigious Canadian Cannabis Awards at the 2018 gala.
Hydropothecary by HEXO took home Cannabis Product of the Year and Innovation of the Year for Elixir. Canada’s first and only peppermint medical cannabis oil sublingual spray, Elixir, is an easy-to-use, discreet and convenient smoke-free method to consume cannabis.
“We are honoured to be here and to accept these awards on behalf of the entire HEXO team,” said HEXO’s co-founder and CBO Adam Miron. “This is an exciting time for HEXO and we have set aggressive goals to continue leading the charge in branding and product innovation. Awards like this are recognition that we are on the right path and continuing to meet our customers’ expectations. Stay curious!”
The awards were held at a gala event at The Carlu in Toronto. HEXO Corp was amongst more than 600 guests, including licensed producers, industry representatives and members of the investor community.
About HEXO Corp.
HEXO Corp. creates and distributes innovative, easy-to-use and easy-to-understand products to serve the Canadian cannabis market. One of the country’s lowest-cost producers, HEXO is rapidly increasing its production capacity in the lead up to the adult-use cannabis market. The Company currently operates with over 310,000 sq. ft. of production capacity with construction on another 1,000,000 sq. ft. expansion set to be complete by year end. HEXO will serve the adult-use market under the HEXO brand, while continuing to serve its medical cannabis clients through the well-known Hydropothecary brand.
<img src=”http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzc0MzkwOTA=” alt=”” width=”1″ height=”1″/>